27665996|t|IFN-γ -producing Th1-like regulatory T cells may limit acute cellular renal allograft rejection: Paradoxical post-transplantation effects of IFN-γ
27665996|a|IFN-γ is a protypical proinflammatory cytokine that plays a central role in inflammation and acute graft rejection. Accumulating evidence indicates that IFN-γ can exert previously unexpected immunoregulatory activities. However, little is known about the role of IFN-γ secreted by Th1-like regulatory T cells in human kidney transplantation. To determine the function of IFN-γ in acute T cell-mediated renal allograft rejection (ACR), we examined serum cytokine expression profiles in ACR patients by human cytokine multiplex immunoassay and analyzed the cellular origins of IFN-γ in peripheral blood and renal allograft biopsies from ACR cases and controls by flow cytometry and immunohistochemistry, respectively. The results showed significant reduction in serum concentrations of Th1 -inducing cytokines IL-12p70 and IFN-γ as well as Th2 -related cytokine IL-4 in ACR patients compared with stable controls. However, levels of several Th1 -, Th2 - and Th17 -related cytokines, such as IL-2, TNF-α, TNF-β, IL-12 (p40), IL-10, IL-15, IL-17, IL-21, and IL-23, as well as the frequencies of Th1 and Th17 cell, did not differ between ACR cases and stable controls. Moreover, we found the levels of IFN-γ were correlated with those of the anti-inflammatory factor, IL-1 receptor antagonist (IL-1Ra) in ACR. Notably, the Th1-like Treg cell -to- Foxp3(-) Th1 cell ratio was significantly lower in ACR patients compared with that in stable controls. In graft biopsies from ACR patients, Treg cells and Th1-like Treg cells were less abundant than those without ACR. Our study indicates that IFN-γ secreted from Th1-like Treg cells negatively modulates ACR.
27665996	0	5	IFN-γ	T116,T121,T129	C3539881
27665996	17	25	Th1-like	T116,T123	C1451170
27665996	26	44	regulatory T cells	T025	C0039198
27665996	55	95	acute cellular renal allograft rejection	T042	C1735634
27665996	97	108	Paradoxical	T080	C0205310
27665996	109	137	post-transplantation effects	T033	C0243095
27665996	141	146	IFN-γ	T116,T121,T129	C3539881
27665996	147	152	IFN-γ	T116,T121,T129	C3539881
27665996	169	193	proinflammatory cytokine	T116,T129	C0079189
27665996	223	235	inflammation	T046	C0021368
27665996	240	261	acute graft rejection	T037	C1736177
27665996	300	305	IFN-γ	T116,T121,T129	C3539881
27665996	338	365	immunoregulatory activities	T040	C0678889
27665996	410	415	IFN-γ	T116,T121,T129	C3539881
27665996	428	436	Th1-like	T116,T123	C1451170
27665996	437	455	regulatory T cells	T025	C0039198
27665996	459	464	human	T016	C0086418
27665996	465	487	kidney transplantation	T061	C0022671
27665996	506	514	function	T169	C0542341
27665996	518	523	IFN-γ	T116,T121,T129	C3539881
27665996	527	574	acute T cell-mediated renal allograft rejection	T042	C1735634
27665996	576	579	ACR	T042	C1735634
27665996	594	599	serum	T031	C0229671
27665996	600	608	cytokine	T116,T129	C0079189
27665996	609	619	expression	T045	C1171362
27665996	632	635	ACR	T042	C1735634
27665996	636	644	patients	T101	C0030705
27665996	648	653	human	T016	C0086418
27665996	654	662	cytokine	T116,T129	C0079189
27665996	673	684	immunoassay	T059	C0020980
27665996	702	718	cellular origins	T078	C0282637
27665996	722	727	IFN-γ	T116,T121,T129	C3539881
27665996	731	747	peripheral blood	T031	C0229664
27665996	752	767	renal allograft	T023	C0564454
27665996	768	776	biopsies	T060	C0005558
27665996	782	785	ACR	T042	C1735634
27665996	808	822	flow cytometry	T059	C0016263
27665996	827	847	immunohistochemistry	T060	C0021044
27665996	894	903	reduction	T080	C0392756
27665996	907	927	serum concentrations	T081	C0683149
27665996	931	934	Th1	T025	C0242632
27665996	945	954	cytokines	T116,T129	C0079189
27665996	955	963	IL-12p70	T116,T121,T129	C0123759
27665996	968	973	IFN-γ	T116,T121,T129	C3539881
27665996	985	988	Th2	T025	C0242633
27665996	998	1006	cytokine	T116,T129	C0079189
27665996	1007	1011	IL-4	T116,T129	C0021758
27665996	1015	1018	ACR	T042	C1735634
27665996	1019	1027	patients	T101	C0030705
27665996	1068	1074	levels	T080	C0441889
27665996	1086	1089	Th1	T025	C0242632
27665996	1093	1096	Th2	T025	C0242633
27665996	1103	1107	Th17	T025	C2936411
27665996	1117	1126	cytokines	T116,T129	C0079189
27665996	1136	1140	IL-2	T116,T129	C0021756
27665996	1142	1147	TNF-α	T116,T129	C1456820
27665996	1149	1154	TNF-β	T116,T129	C0024320
27665996	1156	1167	IL-12 (p40)	T116,T129	C1121402
27665996	1169	1174	IL-10	T116,T129	C0085295
27665996	1176	1181	IL-15	T116,T129	C0254610
27665996	1183	1188	IL-17	T116,T129	C0384648
27665996	1190	1195	IL-21	T116,T129	C0962190
27665996	1201	1206	IL-23	T116,T123	C0963088
27665996	1238	1241	Th1	T025	C0242632
27665996	1246	1255	Th17 cell	T025	C2936411
27665996	1280	1283	ACR	T042	C1735634
27665996	1334	1340	levels	T080	C0441889
27665996	1344	1349	IFN-γ	T116,T121,T129	C3539881
27665996	1384	1408	anti-inflammatory factor	T129	C0021054
27665996	1410	1434	IL-1 receptor antagonist	T116,T121	C1504688
27665996	1436	1442	IL-1Ra	T116,T121	C1504688
27665996	1447	1450	ACR	T042	C1735634
27665996	1465	1473	Th1-like	T116,T123	C1451170
27665996	1474	1483	Treg cell	T025	C0039198
27665996	1489	1497	Foxp3(-)	T028	C1416467
27665996	1498	1501	Th1	T025	C0242632
27665996	1502	1512	cell ratio	T059	C3516452
27665996	1540	1543	ACR	T042	C1735634
27665996	1544	1552	patients	T101	C0030705
27665996	1595	1600	graft	T024	C0332835
27665996	1601	1609	biopsies	T060	C0005558
27665996	1615	1618	ACR	T042	C1735634
27665996	1619	1627	patients	T101	C0030705
27665996	1629	1639	Treg cells	T025	C0039198
27665996	1644	1652	Th1-like	T116,T123	C1451170
27665996	1653	1663	Treg cells	T025	C0039198
27665996	1702	1705	ACR	T042	C1735634
27665996	1711	1716	study	T062	C2603343
27665996	1732	1737	IFN-γ	T116,T121,T129	C3539881
27665996	1752	1760	Th1-like	T116,T123	C1451170
27665996	1761	1771	Treg cells	T025	C0039198
27665996	1793	1796	ACR	T042	C1735634